ClinicalTrials.Veeva

Menu

Initial Non-operative Treatment Strategy Versus Appendectomy Treatment Strategy for Simple Appendicitis in Children (APAC)

R

Ramon Gorter

Status and phase

Active, not recruiting
Phase 4

Conditions

Appendicitis

Treatments

Drug: Augmentin + Gentamicin
Procedure: Appendectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT02848820
APAC2016

Details and patient eligibility

About

OBJECTIVE

The aim of this study is to compare the effectiveness of initial non-operative treatment strategy (reserving appendectomy for those not responding or with recurrent disease) with immediate appendectomy in children from 7 to 17 years old, inclusive, with acute simple appendicitis in terms of complications, health-related QOL and costs.

Main research question: What is the difference in proportion of patients experiencing complications within 1 year between both strategies in children from 7 to 17 years old, inclusive, with acute simple appendicitis?

Full description

Initial non-operative treatment of acute simple appendicitis has recently been investigated in both the adult as the paediatric population. In the adult population, six Randomised Controlled Trial (RCTs) showed that an appendectomy could be avoided in 40-76% of the patients at the end of their follow-up period. Despite the fact that some patients need to undergo a delayed appendectomy, it has been demonstrated in systematic reviews that non-operative treatment strategy is associated with a significant reduction in complications, faster recovery and return to work, less pain duration and analgesic medication consumption. In children only pilot data is yet available. Short-term success rates of this strategy (including of the investigators own pilot cohort study) are between the 83-92%. Long-term results (one-year follow-up) are available from two studies; 62-75% did not require an appendectomy. No large RCT have yet been conducted in the paediatric population. It is therefore essential to generate high quality empirical evidence regarding this strategy in this subset of patients.

Enrollment

302 patients

Sex

All

Ages

7 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 7-17 years

  • Radiologically confirmed simple appendicitis, defined as:

    1. Clinical findings:

      • Unwell, but not generally ill
      • Localized tenderness in the right iliac fossa region
      • Normal/hyperactive bowel sounds
      • No guarding
      • No mass palpable
    2. Ultrasonography:

      • Incompressible appendix with an outer diameter of ≥6 mm
      • Hyperaemia within the appendiceal wall
      • Without faecolith
      • Infiltration of surrounding fat
      • No signs of perforation
      • No signs of intra-abdominal abscess/phlegmon

Exclusion criteria

  • Generalized peritonitis, complex appendicitis or sepsis (based upon predefined criteria and scoring system).

  • Scoring system: As scoring system was developed determining the risk of complex appendicitis based upon five pre-operative variable. Points have been awarded to each variable. In case the total score is less than 4 points, the patient is likely to have a simple appendicitis. In case the score is 4 or more points, the chance of having complex appendicitis is significant and those children will be excluded from this study. Variables:

    • Diffuse abdominal guarding (3 points)
    • C-Reactive Protein level more than 38 mg/L (2 points)
    • Signs on ultrasound indicative of complex appendicitis (2 points)
    • More than one day abdominal pain (2 points)
    • Temperature: more than 37.5 degree Celsius (1 point)
  • Faecolith (ultrasound)

  • Serious co-morbidity

  • Recurrent appendicitis

  • Suspicion of an underlying malignancy or inflammatory bowel disease

  • Documented type 1 allergy to the antibiotics used.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

302 participants in 2 patient groups

Augmentin + Gentamicin
Experimental group
Description:
Initial non-operative treatment strategy reserving an appendectomy for those not responding or with recurrent disease. It consist of: Clinical observation for 48 hours with administration of Intravenous administration of amoxicillin/clavulanic acid 25/2.5mg 6-hourly (total 100/10 mg/kg daily; maximum 6000/600mg a day) and gentamicin 7mg/kg once daily for 48 hours. If after 48 hours the patient fulfils the predefined discharge criteria, the antibiotics will be switched to oral amoxicillin/clavulanic acid 50/12.5 mg/kg 8-hourly (max 1500/375mg a day) for in total 7 days and discharge. An appendectomy is reserved for those patients with clinical deterioration, non-improvement after 72 hours or recurrent appendicitis. Pain medication according to national protocol.
Treatment:
Drug: Augmentin + Gentamicin
Operative treatment strategy
Active Comparator group
Description:
Clinical observation and semi-urgent appendectomy. Pre-, peri- and postoperative care according to local protocol. No routine postoperative antibiotics. Discharge if the patient fulfils the predefined discharge criteria. Pain medication according to national protocol.
Treatment:
Procedure: Appendectomy

Trial contacts and locations

15

Loading...

Central trial contact

Ramon Gorter, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems